Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 11501-11550 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04964934
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
PHASE3Active, not recruiting
315 participants
Started: Jun 30, 2021 · Completed: Nov 26, 2027
1 condition1 sponsor265 locations
NCT05038124
A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone
NAActive, not recruiting
39 participants
Started: Jun 30, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor7 locations
NCT04765111
Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma
PHASE2Active, not recruiting
53 participants
Started: Jun 30, 2021 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT04354675
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
NAActive, not recruiting
35 participants
Started: Jun 29, 2021 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT04411654
Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)
PHASE1/PHASE2Active, not recruiting
7 participants
Started: Jun 29, 2021 · Completed: May 31, 2028
1 condition2 sponsors5 locations
NCT04914741
A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
PHASE1/PHASE2Active, not recruiting
80 participants
Started: Jun 29, 2021 · Completed: Jul 31, 2025
2 conditions2 sponsors15 locations
NCT05045820
Integrative Medicine in Pain Management in Sickle Cell Disease
NAActive, not recruiting
60 participants
Started: Jun 29, 2021 · Completed: Jun 20, 2026
8 conditions2 sponsors1 location
NCT05639218
Impact of Optimal Pharmacotherapy on Lipid Profile and Qualitative Features of Atherosclerotic Plaques
N/AActive, not recruiting
50 participants
Started: Jun 29, 2021 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT04706507
Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis
PHASE3Active, not recruiting
500 participants
Started: Jun 29, 2021 · Completed: Aug 31, 2027
1 condition2 sponsors20 locations
NCT04595266
Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease
PHASE2Active, not recruiting
48 participants
Started: Jun 29, 2021 · Completed: Jan 31, 2026
2 conditions1 sponsor8 locations
NCT04801329
Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy
N/AActive, not recruiting
110 participants
Started: Jun 29, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04780477
Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer
NAActive, not recruiting
60 participants
Started: Jun 29, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04942431
REBIRTH Active School 2.0 . a School Based Physical Activity Program
NAActive, not recruiting
1,245 participants
Started: Jun 28, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04906200
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors
NAActive, not recruiting
400 participants
Started: Jun 28, 2021 · Completed: Aug 31, 2026
22 conditions4 sponsors3 locations
NCT04569097
Novel Pharyngeal Metrics to Predict Dysphagia Outcomes
NAActive, not recruiting
222 participants
Started: Jun 28, 2021 · Completed: Sep 30, 2025
2 conditions1 sponsor3 locations
NCT04925752
Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
PHASE3Active, not recruiting
3,292 participants
Started: Jun 28, 2021 · Completed: May 31, 2028
1 condition1 sponsor91 locations
NCT04846478
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC
PHASE1Active, not recruiting
35 participants
Started: Jun 28, 2021 · Completed: Sep 30, 2026
2 conditions4 sponsors2 locations
NCT04736485
Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT)
PHASE2Active, not recruiting
67 participants
Started: Jun 28, 2021 · Completed: Mar 31, 2027
2 conditions2 sponsors13 locations
NCT05581511
Natural History Study of Cutaneous Neurofibromas in People With NF1
N/AActive, not recruiting
500 participants
Started: Jun 28, 2021 · Completed: Jun 30, 2029
4 conditions2 sponsors1 location
NCT04837092
Phase I/II Study of FR104 First Administration in Patient with Renal Transplantation: FIRsT Study
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Jun 28, 2021 · Completed: Mar 31, 2025
1 condition2 sponsors1 location
NCT04921631
Integrated Supportive and Palliative Care for Older Adults in the ICU
NAActive, not recruiting
1,400 participants
Started: Jun 28, 2021 · Completed: May 31, 2026
1 condition3 sponsors1 location
NCT04817449
Spectroscopy in Ovarian Cancer
N/AActive, not recruiting
160 participants
Started: Jun 28, 2021 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location
NCT04915755
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease
PHASE3Active, not recruiting
40 participants
Started: Jun 28, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor198 locations
NCT04735315
Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
N/AActive, not recruiting
157 participants
Started: Jun 26, 2021 · Completed: Dec 30, 2025
1 condition5 sponsors1 location
NCT05143476
Serum-Protein-Based Indices for the Progression of Fracture Healing and Nonunion
N/AActive, not recruiting
45 participants
Started: Jun 26, 2021 · Completed: Sep 29, 2025
1 condition2 sponsors1 location
NCT04695080
ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis
PHASE2/PHASE3Active, not recruiting
204 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2027
2 conditions6 sponsors22 locations
NCT04895722
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)
PHASE2Active, not recruiting
302 participants
Started: Jun 25, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor109 locations
NCT04806451
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
PHASE3Active, not recruiting
103 participants
Started: Jun 25, 2021 · Completed: Aug 31, 2027
1 condition1 sponsor46 locations
NCT04923880
Pragmatic Implementation Trial of a CF Primary Palliative Care Intervention
NAActive, not recruiting
643 participants
Started: Jun 25, 2021 · Completed: Jun 30, 2024
2 conditions5 sponsors5 locations
NCT04809363
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease
PHASE4Active, not recruiting
200 participants
Started: Jun 25, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor44 locations
NCT04629248
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
PHASE3Active, not recruiting
142 participants
Started: Jun 25, 2021 · Completed: Dec 23, 2027
1 condition1 sponsor50 locations
NCT04950803
A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients
NAActive, not recruiting
448 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04604067
Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.
PHASE2Active, not recruiting
260 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2030
1 condition1 sponsor19 locations
NCT04925024
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
PHASE2Active, not recruiting
40 participants
Started: Jun 25, 2021 · Completed: Aug 31, 2026
1 condition4 sponsors10 locations
NCT04661683
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
NAActive, not recruiting
12 participants
Started: Jun 25, 2021 · Completed: Apr 15, 2026
4 conditions1 sponsor1 location
NCT04472949
Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).
PHASE2Active, not recruiting
46 participants
Started: Jun 25, 2021 · Completed: Dec 31, 2027
2 conditions1 sponsor14 locations
NCT04793958
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
PHASE3Active, not recruiting
461 participants
Started: Jun 24, 2021 · Completed: Jan 30, 2026
2 conditions1 sponsor419 locations
NCT04813042
Determining the Effectiveness of Working Out Dads to Reduce Mental Health Difficulties in Fathers of Young Children
NAActive, not recruiting
293 participants
Started: Jun 24, 2021 · Completed: Nov 30, 2025
1 condition7 sponsors1 location
NCT05171816
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)
PHASE3Active, not recruiting
110 participants
Started: Jun 24, 2021 · Completed: Apr 28, 2026
1 condition2 sponsors26 locations
NCT04801771
Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea
PHASE3Active, not recruiting
57 participants
Started: Jun 24, 2021 · Completed: Sep 30, 2027
2 conditions3 sponsors8 locations
NCT04675710
Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer
PHASE2Active, not recruiting
30 participants
Started: Jun 24, 2021 · Completed: Oct 30, 2026
2 conditions1 sponsor6 locations
NCT06558903
Searching for Predictive Biomarkers of Efficacy in Small Cell Lung Cancer Patients Treated With Chemotherapy-immunotherapy Combination Using Imaging Mass Cytometry (HYPE)
N/AActive, not recruiting
20 participants
Started: Jun 24, 2021 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT04511468
Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression
PHASE2Active, not recruiting
670 participants
Started: Jun 23, 2021 · Completed: Mar 31, 2025
2 conditions2 sponsors1 location
NCT05578677
Endoscopic Biopsy Techniques in Barrett's Esophagus Patients
NAActive, not recruiting
120 participants
Started: Jun 23, 2021 · Completed: Dec 30, 2024
1 condition1 sponsor2 locations
NCT04848753
Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
PHASE3Active, not recruiting
663 participants
Started: Jun 23, 2021 · Completed: May 12, 2027
1 condition1 sponsor48 locations
NCT04261894
The OPTIMIZE Study: Optimizing Patient Navigation for Perinatal Care
NAActive, not recruiting
548 participants
Started: Jun 23, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04936542
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
PHASE4Active, not recruiting
464 participants
Started: Jun 23, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor76 locations
NCT04794218
A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath
PHASE1Active, not recruiting
114 participants
Started: Jun 23, 2021 · Completed: Mar 31, 2024
2 conditions5 sponsors4 locations
NCT04623554
Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer
NAActive, not recruiting
102 participants
Started: Jun 23, 2021 · Completed: Feb 15, 2034
1 condition5 sponsors1 location
NCT04963283
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
PHASE2Active, not recruiting
48 participants
Started: Jun 23, 2021 · Completed: Feb 9, 2026
7 conditions5 sponsors5 locations